Economic Barometer:
NCDP Research Estimates U.S. Spends $218 Billion on Diabetes

When leaders in the health care community discuss the economic impact of diabetes on the United States, the most often cited cost estimate is $174 billion – which represents the direct and indirect costs of type 1 and type 2 diabetes. This important research is part of a study conducted by the Lewin Group for the American Diabetes Association (ADA).

Recently, with encouragement from the ADA, NCDP engaged the Lewin Group to build upon their previous study by expanding the current diabetes economic research model to include undiagnosed, gestational and pre-diabetes.

NCDP’s new Economic Barometer research found that the U.S. spent nearly $218 billion on diabetes and pre-diabetes in 2007. Below is a breakdown of the estimated cost of diabetes:

To view a copy of the research as published in Population Health Management, please click the links below.

• "Medical Cost Associated with Prediabetes" Population Health Management (Journal Article) -- 06/17/2009
• "Cost of Gestational Diabetes Mellitus in the United States in 2007" Population Health Management (Journal Article) -- 06/17/2009
• "The Economic Costs of Undiagnosed Diabetes" Population Health Management (Journal Article) -- 04/10/2009
• "Distinguishing the Economic Costs Associated with Type 1 and Type 2 Diabetes" Population Health Management (Journal Article) -- 04/10/2009

To view all abstracts, click here.

To access all research in one convenient PDF, click here.

To see media & coverage the Economic Barometer, visit the Media page.

For more information or inquiries, please contact: Erin Byrne